Cardiovascular pathology in patients with newly diagnosed tuberculosis and chronic obstructive pulmonary disease

Introduction. Chronic obstructive pulmonary disease and cardiovascular diseases (arterial hypertension, ischemic heart disease, chronic heart failure) are among the comorbid conditions that mutually aggravate each other. The addition of tuberculosis in this category of patients requires additional efforts from the doctor to improve treatment outcomes.
Purpose. Тo assess the prevalence of chronic obstructive pulmonary disease, arterial hypertension, coronary heart disease and chronic heart failure in patients with newly diagnosed tuberculosis hospitalized in an anti-tuberculosis hospital.
Materials and methods. We examined 462 patients with newly diagnosed tuberculosis, hospitalized in a tuberculosis dispensary, aged 17 to 88 years, the median (Me (P25; 75) age was 43.68 (32.00; 54.00) years, including 266 men (57.6%) and 196 women (42.4%) All patients underwent clinical, laboratory, instrumental examination to establish or confirm the diagnosis.
Results. The incidence of chronic obstructive pulmonary disease among patients with newly diagnosed tuberculosis was 31.4%, with arterial hypertension – 12.1%, coronary heart disease – 6.1%, chronic heart failure – 6.1%. The incidence of cardiovascular pathology in the group of tuberculosis + chronic obstructive pulmonary disease was 40%, in the group of tuberculosis without chronic obstructive pulmonary disease 6%.
Conclusions. The prevalence of comorbid cardiovascular pathology in patients with tuberculosis + chronic obstructive pulmonary disease is significantly higher than among patients with only tuberculosis, which requires the involvement of doctors of various specialties to manage this category of patients to prevent adverse treatment outcomes, disability and mortality.

1. Vizel’ A.A., Vizel’ I.Yu. Chronic obstructive pulmonary disease: state of the problem 2016. Lechaschi Vrach. 2016;(4):78. (In Russ.) Available at: https://www.lvrach.ru/2016/04/15436448.

2. Khanin A.L., Kravets S.L. Chronic obstructive pulmonary disease and tuberculosis: an urgent problem in real practice (literature review). Vestnik sovremennoi klinicheskoi meditsiny = The Bulletin of Contemporary Clinical Medicine. 2017;10(6):60–70. (In Russ.) https://doi.org/10.20969/VSKM.2017.10(6).60-70.

3. Mordyk A.V., Bagisheva N.V., Vershinina M.V. Smoking, chronic obstructive pulmonary disease and tuberculosis: constituent problems. Omsk: Publishing Center KAN; 2018. 126 p. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=38515796.

4. Bagisheva N.V., Mordyk A.V., Mordyk D.I. COPD and tuberculosis: is there a link? Meditsinskiy vestnik Severnogo Kavkaza = Medical News of North Caucasus. 2019;14(1–1):135–140. (In Russ.) https://doi.org/10.14300/mnnc.2019.14070.

5. GOLD. Global Strategy for the Diagnosis, Management and Prevention of COPD (2019 report). 2019. 155 p. Available at: https://goldcopd.org/wpcontent/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf.

6. Bagisheva N.V., Mordyk A.V., Nesterova K.I., Goltyapin V.V., Aroyan A.R., Rudenko S.A., Shirinskaya N.V. Factor analysis of socio-demographic preconditions for tuberculosis development in patients with chronic obstructive lung disease. Vestnik sovremennoy klinicheskoy meditsiny = The Bulletin of Contemporary Clinical Medicine. 2021;14(1):7–15. (In Russ.) https://doi.org/10.20969/VSKM.2021.14(1).7-15.

7. Trukhan D.I., Filimonov S.N., Bagisheva N.V. Diseases of respiratory organs: topical aspects of diagnosis and treatment. Novokuznetsk: Poligrafist; 2020. 227 p. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=41882462.

8. Aisanov Z.R., Chuchalin A.G., Kalmanova E.N. Chronic obstructive pulmonary disease and cardiovascular comorbidity. Kardiologiya. 2019;59(8S):24–36. (In Russ.): https://doi.org/10.18087/cardio.2572.

9. Bagisheva N.V., Mordyk A.V., Viktorova I.A., Nesterova K.I., Goltyapin V.V., Aroyan A.R. et al. Factor analysis of medical risk factors for the development of an unfavorable outcome of tuberculosis treatment in comorbid patients. Farmateka. 2021;28(5):96–102. (In Russ.) https://doi.org/10.18565/pharmateca.2021.5.96-102.

10. Chen W., Thomas J., Sadatsafavi M., FitzGerald J.M. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631–639. https://doi.org/10.1016/s2213-2600(15)00241-6.

11. Yablonsky P.K., Sukhovskaya O.A. Initiatives to help in smoking cessation. Meditsinskiy Alyans = Medical Alliance. 2015;(4):48–52. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=26292784.

12. Arutyunov A.G., Dragunov D.O., Arutyunov G.P., Rylova A.K., Pashkevich D.D., Viter K.V. et al. First Open Study of Syndrome of Acute Decompensation of Heart Failure and Concomitant Diseases in Russian Federation: Independent Registry ORAKUL. Kardiologiya. 2015;55(5):12–21. (In Russ.) Available at: https://aritmologi.org/publikacii/pervoe-otkrytoe-issledovaniesindroma-ostroy-dekompensacii-serdechnoy-nedostatochnosti-i-soputstvuyushhich-zabolevaniy/

13. Chuchalin A.G., Arutyunov G.P., Sinopalnikov A.I., Avdeev S.N., Zyryanov S.K., Arutyunov A.G. Expert consensus on treatment of pneumonia in patients with circulatory decompensation. Zhurnal Serdechnaya Nedostatochnost = Russian Heart Failure Journal. 2016;17(3):212–228. (In Russ.) Available at: https://euat.ru/upload/recommendation/1527072521.pdf.

14. Vanfleteren L.E.G.W., Spruit M.A., Wouters E.F.M., Franssen F.M.E. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med. 2016;4(11):911–924. https://doi.org/10.1016/S2213-2600(16)00097-7.

15. Yablonsky Р.K. (ed.). Phthisiology: national clinical guidelines. Moscow: GEOTAR-Media; 2015. 240 p. (In Russ.) Available at: https://elibrary.ru/item.asp?id=25784141.

16. Vasileva I.A., Balasanyants G.S., Borisov S.E., Burmistrova I.A., Valiev R.Sh., Vaniev E.V. et al. Tuberculosis in adults: clinical guidelines. Moscow; 2020. 121 p. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=42593525.

17. Vаsilyevа I.A., Belilovsky E.M., Borisov S.E., Sterlikov S.A. Incidence, mortality and prevalence as indicators of tuberculosis burden in WHO regions, countries of the world and the Russian Federation. Part 1. Tuberculosis incidence and prevalence. Tuberkulez i bolezni legkikh = Tuberculosis and Lung Disease. 2017;95(6):9–21. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-6-9-21.

18. Kopylova I.F., Kobeleva G.V., Pyanzova T.V., Bayborodova T.I. Changes in lethal outcomes in tuberculosis cases over 17 years in kemerovo region. Tuberkulez i bolezni legkikh = Tuberculosis and Lung Diseases. 2016;94(7):25–29. (In Russ.) https://doi.org/10.21292/2075-1230-2016-94-7-25-29.

19. Bagisheva N.V., Gol’tyapin V.V., Mordyk A.V., Mordyk D.I. Chronic obstructive pulmonary disease and newly diagnosed tuberculosis: factors affecting the outcome of the pathological process. Farmateka. 2018;(13):44–50. (In Russ.) https://doi.org/10.18565/pharmateca.2018.13.44-50.

20. Bagisheva N., Mordyk A., Goltyapin V. Prediction of the results of tuberculosis treatment in patients with chronic obstructive lung disease. Meditsinskiy Alyans = Medical Alliance. 2019;(1):13–19. (In Russ.) Available at: https://med-alyans.ru/index.php/Hahn/article/view/559.

21. Shubina A.T., Borodulina E.A., Gerasimov A.N., Yakovleva E.V. Pulmonary tuberculosis in clinical practice. Sibirskiy nauchnyy meditsinskiy zhurnal = Siberian Scientific Medical Journal. 2021;41(3):78–84. (In Russ.) Available at: https://sibmed.elpub.ru/jour/article/viewFile/607/353.pdf.

22. Slogotskaya L.V., Bogorodskaya Е., Ivanova D., Makarova M., Guntupova L., Litvinov V. et al. Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non-tuberculosis diseases. Eur Resp J. 2013;42(S57):1995. Available at: https://erj.ersjournals.com/content/42/Suppl_57/1995.

23. Yablonskii P.K., Vizel A.A., Galkin V.B., Shulgina M.V. Tuberculosis in Russia. Its history and its status today. Am J Respir Crit Care Med. 2015;191(4):372–376. https://doi.org/10.1164/rccm.201305-0926oe.

24. Elkina I.A., Pyanzova T.V. Treatment efficiency in new tuberculosis cases depending on HIV status. Tuberkulez i bolezni legkikh = Tuberculosis and Lung Disease. 2018;96(5):52–53. (In Russ.) https://doi.org/10.21292/2075-1230-2018-96-5-52-53.

25. Moiseeva M., Bagisheva N., Mordyk A., Ivanova O., Ivanchenko A., Nazhmutdinova A., Shamsheva E., Mordyk D. Echocardiographic features of patients with chronic obstructive pulmonary disease and newly diagnosed tuberculosis. Vrach (The Doctor). 2019;30(2):48–51. (In Russ.) https://doi.org/10.29296/25877305-2019-02-09.

26. Viktorova I.A., Bagisheva N.V., Moiseeva M.V., Mordyk A.V., Aroyan A.R., Filipenko G.V. et al. Optimization of antihypertensive therapy in co-morbid patients with pulmonary tuberculosis, chronic obstructive pulmonary disease and arterial hypertension. Sibirskoe meditsinskoe obozrenie = Siberian Medical Review. 2020;122(2):36–44. (In Russ.) Available at: https://elibrary.ru/item.asp?id=42839051.

27. Viktorova I.A., Bagisheva N.V., Moiseeva M.V., Mordyk A.V., Aroyan A.R., Filipenko G.V. et al. Treatment for ischemic heart disease in patients with tuberculosis and chronic obstructive pulmonary disease. RMZh = RMJ. 2021;29(1):10–16. (In Russ.) Available at: https://www.rmj.ru/articles/kardiologiya/Osobennosti_terapii_ishemicheskoy_bolezni_serdca_u_pacientov_s_tuberkulezom_i_hronicheskoy_obstruktivnoy_boleznyyu_legkih/.

28. Viktorova I.A., Ivanova D.S., Trukhan D.I., Bagisheva N.V., Bulakhova E.Yu., Adyrbaev A.M., Kochimov R.Sh. Choice of treatment policy for patient with coronary heart disease: clinical discussion. Consilium Medicum. 2020;22(5):77–82. (In Russ.) Available at: https://www.consilium.orscience.ru/archive/2020/vybor-lechebnoy-taktiki-pri-ishemicheskoy-bolezniserdtsa-klinicheskiy-razbor_7490/?element.

29. Bagisheva N.V., Mordyk A.V., Moiseeva M.V., Nesterova K.I., Nebesnaya E.Yu., Filipenko G.V. et al. The opportunities of cardioprotective therapy: patients with tb and chronic obstructive pulmonary disease in focus. Vestnik Tsentralnogo nauchno-issledovatelskogo instituta tuberkuleza = Bulletin of the Central Research Institute of Tuberculosis. 2021;(1):65–75. (In Russ.) https://doi.org/10.7868/S2587667821010088.

30. Drapkina O.M., Livzan M.A., Martynov A.I., Moiseev S.V., Nikolaev N.A., Skirdenko Yu.P. The first Russian consensus on quantifying adherence to treatment: basic provisions, algorithms and recommendations. Meditsinskiy vestnik Severnogo Kavkaza = Medical News of the North Caucasus. 2018;13(1–2): 259–271. (In Russ.) https://doi.org/10.14300/mnnc.2018.13039.